Predictors of return to work ten months after primary breast cancer surgery

Figures & data

Table I.  Demographic and social characteristics at inclusion.

	n
Age
35–50	31
51–63	66
Educational level
Nine-year school/Upper secondary school	64
University	33
Living with husband/partner
Yes	64
No	33
Living with child <18 years of age
Yes	19
No	78
Born in Sweden
Yes	81
No	16
Sick-leave days in last 12 months
0–30	55
> 30 days due to the breast cancer diagnosis	24
> 30 days due to other diagnosis	13
Missing	5
Self-rated health
Very good or good	68
Fair, poor, or very poor	28
Missing	1
Manual work
Yes	19
No	76
Missing	2
Full-time job
Yes	74
No	23
Job strain
Low demand/high control	59
High demand/high control	14
Low demand/low control	18
High demand/low control	4
Missing	2

Table II.  Surgery and adjuvant treatment characteristics.

	n
Breast surgery
Mastectomy without immediate breast reconstruction	36
Mastectomy with immediate breast reconstruction	4
Sector resection	57
Axillary surgery
Axillary node dissection	72
Only sentinel node or no axillary node dissection	25
Irradation (RT)
RT only to breast parenchyma	52
RT to breast/chest wall and regional nodes	14
No RT	31
Chemotherapy
Chemotherapy	31
No chemotherapy	66
Endocrine therapy
Endocrine therapy	90
No endocrine therapy	7

Table III.  Crude and adjusted odds ratio (95% confidence interval) for having returned to work 10 months after breast cancer surgery (97 women).

Variable	Crude OR (95% CI)	Adjusted OR (95% CI)
Age
35–50	1.0	1.0
51–63	1.9 (0.8–4.4)	1.9 (0.5–7.1)
Sick-leave days in the last 12 months
0–30 days	1.0	1.0
> 30 days	0.4 (0.2–1.0)	0.4 (0.1–1.6)
Self-rated health
Very good or good	1.0	1.0
Fair, poor, or very poor	0.2 (0.1–0.6)	0.4 (0.1–1.8)
LiSat–Life as a whole
Satisfied	1.0	1.0
Not satisfied	0.4 (0.2–1.0)	1.4 (0.4–5.6)
LiSat–Vocational situation
Satisfied	1.0	1.0
Not satisfied	0.4 (0.2–0.9)	0.3 (0.1–1.2)
Job strain
Low demand	1.0	1.0
High demand	0.5 (0.1–0.8)	0.1 (0.0–0.8)
Axillary dissection
No	1.0	1.0
Yes	0.1 (0.0–0.4)	0.1 (0.0–0.6)
RT to breast/chest wall and regional nodes
No	1.0	1.0
Yes	0.0 (0.0–0.3)	0.3 (0.0–3.7)
Chemotherapy
No	1.0	1.0
Yes	0.1 (0.0–0.3)	0.1 (0.0–0.7)